TARSUS PHARMACEUTICALS, INC. Amortization of Debt Issuance Costs and Discounts
TARSUS PHARMACEUTICALS, INC. (TARS) reported Amortization of Debt Issuance Costs and Discounts of $325.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2026-08-06
- TARSUS PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for the quarter ending 2026-06-30 was $166.00K, a 13.70% increase year-over-year.
- TARSUS PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for the quarter ending 2026-03-31 was $159.00K, a 14.39% increase year-over-year.
- TARSUS PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for the quarter ending 2025-12-31 was $156.00K, a 13.04% increase year-over-year.
- TARSUS PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for the quarter ending 2025-09-30 was $152.00K, a 17.83% increase year-over-year.
- TARSUS PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for fiscal 2025 was $593.00K, a 23.03% increase from fiscal 2024.
- TARSUS PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for fiscal 2024 was $482.00K, a 25.19% increase from fiscal 2023.
- TARSUS PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for fiscal 2023 was $385.00K, a 24.60% increase from fiscal 2022.
- TARSUS PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for fiscal 2022 was $309.00K.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2026-06-30 | $166.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $325.00K 10-Q · filed 2026-08-06 | $481.00K derived: sum of 3 quarters · filed 2026-08-06 | $633.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $159.00K 10-Q · filed 2026-05-06 | $315.00K derived: sum of 2 quarters · filed 2026-05-06 | $467.00K derived: sum of 3 quarters · filed 2026-05-06 | $613.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $308.00K derived: sum of 2 quarters · filed 2026-02-23 | $454.00K derived: sum of 3 quarters · filed 2026-08-06 | $593.00K 10-K · filed 2026-02-23 |
| 2025-09-30 | $152.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $298.00K derived: sum of 2 quarters · filed 2026-08-06 | $437.00K 10-Q · filed 2025-11-04 | $575.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $146.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $285.00K 10-Q · filed 2026-08-06 | $423.00K derived: sum of 3 quarters · filed 2026-08-06 | $552.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $139.00K 10-Q · filed 2026-05-06 | $277.00K derived: sum of 2 quarters · filed 2026-05-06 | $406.00K derived: sum of 3 quarters · filed 2026-05-06 | $507.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $267.00K derived: sum of 2 quarters · filed 2026-02-23 | $368.00K derived: sum of 3 quarters · filed 2026-02-23 | $482.00K 10-K · filed 2026-02-23 |
| 2024-09-30 | $129.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $230.00K derived: sum of 2 quarters · filed 2025-11-04 | $344.00K 10-Q · filed 2025-11-04 | $455.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | $101.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $215.00K 10-Q · filed 2025-08-06 | $326.00K derived: sum of 3 quarters · filed 2026-02-23 | $427.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | $114.00K 10-Q · filed 2025-05-01 | $225.00K derived: sum of 2 quarters · filed 2026-02-23 | $326.00K derived: sum of 3 quarters · filed 2026-02-23 | $418.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | $111.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $212.00K derived: sum of 2 quarters · filed 2026-02-23 | $304.00K derived: sum of 3 quarters · filed 2026-02-23 | $385.00K 10-K · filed 2026-02-23 |
| 2023-09-30 | $101.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $193.00K derived: sum of 2 quarters · filed 2024-11-13 | $274.00K 10-Q · filed 2024-11-13 | $352.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $173.00K 10-Q · filed 2024-08-08 | $251.00K derived: sum of 3 quarters · filed 2025-02-25 | $345.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $81.00K 10-Q · filed 2024-05-08 | $159.00K derived: sum of 2 quarters · filed 2025-02-25 | $253.00K derived: sum of 3 quarters · filed 2025-02-25 | $335.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $172.00K derived: sum of 2 quarters · filed 2025-02-25 | $254.00K derived: sum of 3 quarters · filed 2025-02-25 | $309.00K 10-K · filed 2025-02-25 |
| 2022-09-30 | $94.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $176.00K derived: sum of 2 quarters · filed 2023-11-09 | $231.00K 10-Q · filed 2023-11-09 | $231.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $82.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $137.00K 10-Q · filed 2023-08-10 | $137.00K derived: sum of 3 quarters · filed 2023-08-10 | $137.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $55.00K 10-Q · filed 2023-05-09 | $55.00K derived: sum of 2 quarters · filed 2023-05-09 | $55.00K derived: sum of 3 quarters · filed 2023-05-09 | $55.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $0.00 derived: sum of 2 quarters · filed 2023-03-17 | $0.00 derived: sum of 3 quarters · filed 2023-03-17 | $0.00 10-K · filed 2023-03-17 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |